Business · 10/05/2023

FDA Releases Final Guidance on Testing of High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol

The FDA has released a final guidance to help pharmaceutical manufacturers and suppliers prevent the use of contaminated high-risk drug components, including glycerin and propylene glycol, that can lead to consumer poisoning.